[December 11, 2012]

Research and Markets: Global CNS Disorders Drug Pipeline Capsule - 2012

Research and Markets (http://www.researchandmarkets.com/research/mv3bdf/global_cns) has announced the addition of the "Global CNS Disorders Drug Pipeline Capsule - 2012" report to their offering.

Fore Pharma's latest report Global CNS Disorders Drug Pipeline Capsule - 2012' provides up-to-date information on key research and development activities in the global central nervous system (CNS) disorders drug market. It covers active pipeline molecules under development in various stages of clinical trials, preclinical research, an drug discovery for Alzheimer's disease, Epilepsy, Insomnia, Schizophrenia, Parkinson's disease, Bipolar Disorders, and Multiple Sclerosis.

This report helps executives track their competitor's pipeline molecules. The information presented in this report can be used for identifying partners, evaluating business opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company, mechanism of action, stage (phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and drug discovery), and geography (North America, Europe, and Asia).

Key Features of the Report:

- CNS Disorders Drug Pipeline Insights

- Alzheimer's Disease Drug Pipeline Insights

- Epilepsy Drug Pipeline Insights

- Insomnia Drug Pipeline Insights

- Schizophrenia Drug Pipeline Insights

- Parkinson's Disease Drug Pipeline Insights

- Bipolar Disorders Drug Pipeline Insights

- Multiple Sclerosis Drug Pipeline Insights

For more information visit http://www.researchandmarkets.com/research/mv3bdf/global_cns

[ Back To Technology News's Homepage ]